{"doi":"10.1093/bjs/znad240","title":"Appendiceal neoplasms in patients treated with antibiotics for acute appendicitis: secondary analysis of the CODA randomized clinical trial","abstract":"Several randomized trials have demonstrated the use of antibiotics as a safe and effective alternative to appendectomy for the treatment of acute appendicitis1,2. With non-operative management increasingly offered as an alternative treatment for appendicitis, there is the possibility that some appendiceal neoplasms might remain undetected. In the US general population, appendiceal cancer is rare, with an incidence of 0.97/100 000 person-years3. Previous series have reported that 0.5–1 per cent of those who undergo appendectomy for acute appendicitis are found to have appendiceal neoplasms4–6. Uncertainty remains about the clinical impact of occult neoplasms in the setting of increasing non-operative management of appendicitis7. Additionally, prior studies of antibiotics in the treatment of appendicitis variably used CT imaging as part of the diagnostic evaluation for appendicitis. Interestingly, the accuracy of CT imaging for neoplasms in patients presenting with appendicitis has not been determined. In this secondary analysis of the Comparison of Antibiotic Drugs and Appendectomy (CODA) trial, the aim was to describe the prevalence, time until detection, and cancer stage of those found to have neoplasms after acute appendicitis and to determine the diagnostic accuracy of CT imaging for neoplasms. This secondary analysis of the CODA trial (registration number: NCT02800785; http://www.clinicaltrials.gov), conducted at 25 sites between May 2016 and February 2020, included 22 patients excluded from the trial for CT imaging suspicious for neoplasms and for whom pathology data were available, and 2062 patients without radiographic suspicion for neoplasms (1384 with CT and 678 with transabdominal ultrasound) who otherwise met criteria for enrolment into either the randomized cohort (1522) or a non-randomized parallel observational cohort (510). Data were collected retrospectively in accordance with CODA protocol (Supplementary Protocol 4.1.1)1. Suspicion for appendiceal neoplasms on CT imaging was noted if there was a solid mass or other findings consistent with tumour, mucocele, or carcinomatosis in the radiology report. Appendiceal neoplasms were classified as such if the pathology report included a diagnosis of an adenocarcinoma, a high- or low-grade mucinous neoplasm (HAMN or LAMN), a neuroendocrine tumour (NET), or a sessile serrated adenoma (SSA)8–10. Grading and staging were classified in accordance with the AJCC Cancer Staging Manual (8th edn)11,12. The Writing Group calculated the positive predictive value (PPV) and negative predictive value (NPV) of CT imaging for detection of appendiceal neoplasms using data from patients excluded from trial participation due to CT imaging suspicious for appendiceal neoplasms and those in either randomized or observational cohort for whom pathology data were available post hoc. The Writing Group calculated the prevalence of appendiceal neoplasms using participants of either the randomized or observational cohort of the study. Data analysis consisted of descriptive statistics, including the Wilson score method for 95 per cent c.i. calculations. Of 2062 patients enrolled into the CODA trial for acute appendicitis without imaging suspicious for neoplasms, a total of 12 patients (mean age of 46 years, age range of 21 to 74 years, and 50 per cent male), that is 0.6 per cent (95 per cent c.i. 0.3 to 1.0 per cent), were found to have histopathologically confirmed appendiceal neoplasms. There were 7 of 1029, that is 0.7 per cent (95 per cent c.i. 0.3 to 1.4 per cent), who underwent appendectomy at index admission and 5 of 1033, that is 0.5 per cent (95 per cent c.i. 0.2 to 1.1 per cent), who initially underwent antibiotic management and were subsequently found to have appendiceal neoplasms. For patients who initially underwent antibiotic management for appendicitis, the median time to diagnosis of an appendiceal neoplasm was 91 (range 36–232) days. The median follow-up time for all 1033 patients ","journal":"British journal of surgery","year":2023,"id":360986,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":9,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9425,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":266654,"name":"Frank Yang","orcid":"0000-0001-6901-9293","position":1,"is_corresponding":false},{"id":369222,"name":"Sarah E. Monsell","orcid":"0000-0002-2563-534X","position":2,"is_corresponding":false},{"id":666931,"name":"Giana H. Davidson","orcid":"0000-0002-6197-2618","position":3,"is_corresponding":false},{"id":528270,"name":"Harveshp Mogal","orcid":"0000-0001-5743-1424","position":4,"is_corresponding":false},{"id":856320,"name":"Emily C. Voldal","orcid":"0000-0002-6286-3982","position":5,"is_corresponding":false},{"id":968792,"name":"Erin Fannon","orcid":null,"position":6,"is_corresponding":false},{"id":968298,"name":"Sarah O Lawrence","orcid":"0000-0002-1809-8718","position":7,"is_corresponding":false},{"id":412567,"name":"Anusha Krishnadasan","orcid":null,"position":8,"is_corresponding":false},{"id":411335,"name":"David A. Talan","orcid":"0000-0002-7048-8086","position":9,"is_corresponding":false},{"id":968791,"name":"Bonnie Bizzell","orcid":null,"position":10,"is_corresponding":false},{"id":373971,"name":"Patrick J. Heagerty","orcid":"0000-0002-3403-6007","position":11,"is_corresponding":false},{"id":695354,"name":"Bryan A. Comstock","orcid":"0000-0003-2599-1608","position":12,"is_corresponding":false},{"id":369215,"name":"Danielle C. Lavallee","orcid":"0000-0002-5555-9675","position":13,"is_corresponding":false},{"id":270159,"name":"Damien Carter","orcid":"0000-0003-3988-4459","position":14,"is_corresponding":false},{"id":370373,"name":"Dionne A. Skeete","orcid":null,"position":15,"is_corresponding":false},{"id":230563,"name":"Hasan B. Alam","orcid":"0000-0002-1024-5226","position":16,"is_corresponding":false},{"id":1112788,"name":"Jacob Glaser","orcid":"0000-0002-9297-7913","position":17,"is_corresponding":false},{"id":1096464,"name":"Katherine Mandell","orcid":null,"position":18,"is_corresponding":false},{"id":412579,"name":"Lisandra Uribe","orcid":null,"position":19,"is_corresponding":false},{"id":331516,"name":"Miriam Y. Neufeld","orcid":"0000-0003-0027-6392","position":20,"is_corresponding":false},{"id":1113183,"name":"Mary Guiden","orcid":null,"position":21,"is_corresponding":false},{"id":1113184,"name":"Shaina Schaetzel","orcid":null,"position":22,"is_corresponding":false},{"id":1112789,"name":"Shelby Reiter","orcid":"0000-0002-7548-3786","position":23,"is_corresponding":false},{"id":1112790,"name":"Stefanos G. Millas","orcid":"0000-0001-9756-8046","position":24,"is_corresponding":false},{"id":1095810,"name":"Robert J. Winchell","orcid":"0000-0002-6276-233X","position":25,"is_corresponding":false},{"id":846349,"name":"Callie M Thompson","orcid":"0000-0002-1529-5687","position":26,"is_corresponding":false},{"id":106002,"name":"Wesley H. Self","orcid":"0000-0002-9300-3045","position":27,"is_corresponding":false},{"id":492071,"name":"Lillian S. Kao","orcid":"0000-0002-3567-8159","position":28,"is_corresponding":false},{"id":737891,"name":"Shah-Jahan M. Dodwad","orcid":null,"position":29,"is_corresponding":false},{"id":1113185,"name":"Darin Salzman","orcid":null,"position":30,"is_corresponding":false},{"id":684600,"name":"Amy H. Kaji","orcid":"0000-0003-4588-7939","position":31,"is_corresponding":false},{"id":711383,"name":"Daniel A. DeUgarte","orcid":"0000-0002-6088-902X","position":32,"is_corresponding":false},{"id":968294,"name":"Nicole Siparsky","orcid":"0000-0002-9438-8274","position":33,"is_corresponding":false},{"id":968790,"name":"Thea P. Price","orcid":null,"position":34,"is_corresponding":false},{"id":968293,"name":"Jesse Victory","orcid":"0000-0002-2399-9035","position":35,"is_corresponding":false},{"id":15369,"name":"Alan E. Jones","orcid":"0000-0001-5772-6222","position":36,"is_corresponding":false},{"id":417808,"name":"Matthew Kutcher","orcid":"0000-0003-4566-5359","position":37,"is_corresponding":false},{"id":968297,"name":"Mike K. Liang","orcid":"0000-0001-7063-7291","position":38,"is_corresponding":false},{"id":492267,"name":"Joseph Cuschieri","orcid":"0000-0003-1456-6841","position":39,"is_corresponding":false},{"id":779573,"name":"Jeffrey Johnson","orcid":"0000-0003-2912-443X","position":40,"is_corresponding":false},{"id":968787,"name":"Stephen R. Odom","orcid":null,"position":41,"is_corresponding":false},{"id":768312,"name":"Larry G. Kessler","orcid":"0000-0002-8024-5424","position":42,"is_corresponding":false},{"id":463595,"name":"David R. Flum","orcid":"0000-0002-7288-0436","position":43,"is_corresponding":false},{"id":1096460,"name":"writing group for the CODA Collaborative","orcid":null,"position":0,"is_corresponding":true}],"reference_count":16,"raw_metadata":null,"created_at":"2026-07-19T01:14:06.433417Z","pmid":"37499092","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}